Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Terry Kenakin, Laurence J. Miller
Pharmacological Reviews (2010) Vol. 62, Iss. 2, pp. 265-304
Open Access | Times Cited: 559

Showing 26-50 of 559 citing articles:

Distinct profiles of functional discrimination among G proteins determine the actions of G protein–coupled receptors
Ikuo Masuho, Olga Ostrovskaya, Grant M. Kramer, et al.
Science Signaling (2015) Vol. 8, Iss. 405
Open Access | Times Cited: 245
The Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Daniele Bolognini, Andrew B. Tobin, Graeme Milligan, et al.
Molecular Pharmacology (2015) Vol. 89, Iss. 3, pp. 388-398
Open Access | Times Cited: 242
Pharmacological modulation of chemokine receptor function
Danny J. Scholten, Meritxell Canals, David Maussang, et al.
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1617-1643
Open Access | Times Cited: 240
Detection of Antigen Interactions Ex Vivo by Proximity Ligation Assay: Endogenous Dopamine D2-Adenosine A2A Receptor Complexes in the Striatum
Pierre Trifilieff, M. Rives, Eneko Urizar, et al.
BioTechniques (2011) Vol. 51, Iss. 2, pp. 111-118
Open Access | Times Cited: 240
Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state
Jianyun Huang, Daiwen Chen, J Jillian Zhang, et al.
Nature Structural & Molecular Biology (2013) Vol. 20, Iss. 4, pp. 419-425
Open Access | Times Cited: 239
PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
Melpomeni Fani, Luigi Del Pozzo, K. Abiraj, et al.
Journal of Nuclear Medicine (2011) Vol. 52, Iss. 7, pp. 1110-1118
Open Access | Times Cited: 238
G-Protein-Coupled Receptors in Intestinal Chemosensation
Frank Reimann, Gwen Tolhurst, Fiona M. Gribble
Cell Metabolism (2012) Vol. 15, Iss. 4, pp. 421-431
Open Access | Times Cited: 228
Biased signalling and allosteric machines: new vistas and challenges for drug discovery
Terry Kenakin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1659-1669
Open Access | Times Cited: 227
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
Arthur Christopoulos, Jean‐Pierre Changeux, William A. Catterall, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 4, pp. 918-947
Open Access | Times Cited: 223
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols, P. Jeffrey Conn
Neurobiology of Disease (2013) Vol. 61, pp. 55-71
Open Access | Times Cited: 216
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Arthur Christopoulos
Molecular Pharmacology (2014) Vol. 86, Iss. 5, pp. 463-478
Open Access | Times Cited: 213
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204
Novel Allosteric Modulators of G Protein-coupled Receptors
Patrick R. Gentry, Patrick M. Sexton, Arthur Christopoulos
Journal of Biological Chemistry (2015) Vol. 290, Iss. 32, pp. 19478-19488
Open Access | Times Cited: 188
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Louis M. Luttrell, Stuart Maudsley, Laura Bohn
Molecular Pharmacology (2015) Vol. 88, Iss. 3, pp. 579-588
Open Access | Times Cited: 180
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong, Calvin Ly, Lee E. Dunlap, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2779-2792.e18
Open Access | Times Cited: 139
Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
Yang Liu, Qiang Guo, Heng Yang, et al.
ACS Central Science (2022) Vol. 8, Iss. 8, pp. 1102-1115
Open Access | Times Cited: 85
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrow
Jacques Fantini, Fodil Azzaz, Coralie Di Scala, et al.
Pharmacology & Therapeutics (2025), pp. 108797-108797
Open Access | Times Cited: 2
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith, Graeme Milligan
Pharmacological Reviews (2010) Vol. 62, Iss. 4, pp. 701-725
Open Access | Times Cited: 246
Dynamic Allostery: Linkers Are Not Merely Flexible
Buyong Ma, Chung‐Jung Tsai, Türkan Haliloğlu, et al.
Structure (2011) Vol. 19, Iss. 7, pp. 907-917
Open Access | Times Cited: 217
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, et al.
Journal of Medicinal Chemistry (2011) Vol. 55, Iss. 4, pp. 1445-1464
Open Access | Times Cited: 216
Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
Stephan Urwyler
Pharmacological Reviews (2011) Vol. 63, Iss. 1, pp. 59-126
Closed Access | Times Cited: 199
Allostery and population shift in drug discovery
Gozde Kar, Özlem Keskin, Attila Gürsoy, et al.
Current Opinion in Pharmacology (2010) Vol. 10, Iss. 6, pp. 715-722
Open Access | Times Cited: 179
Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells
R Schröder, Johannes Schmidt, Stefanie Blättermann, et al.
Nature Protocols (2011) Vol. 6, Iss. 11, pp. 1748-1760
Closed Access | Times Cited: 170
Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease
Morley D. Hollenberg, Koichiro Mihara, Danny Polley, et al.
British Journal of Pharmacology (2013) Vol. 171, Iss. 5, pp. 1180-1194
Open Access | Times Cited: 168

Scroll to top